New Study Recommends Shorter, Flexible Monitoring After CAR T-Cell Therapy - CGTLive®

Retrieved on: 2024-08-01 19:18:06

Tags for this article:

Click the tags to see associated articles and topics

New Study Recommends Shorter, Flexible Monitoring After CAR T-Cell Therapy - CGTLive®. View article details on hiswai:

Excerpt

Umoja Biopharma's In Situ CAR-T Therapy Cleared for US Trial in Hematologic Malignancies. Aug 1, 2024. By Noah Stansfield.

Article found on: www.cgtlive.com